首页> 外国专利> Oral, immediate release formulation in solid form for prophylaxis and/or treatment of thrombo-embolism and process for preparing thereof

Oral, immediate release formulation in solid form for prophylaxis and/or treatment of thrombo-embolism and process for preparing thereof

机译:固体形式的口服速释制剂,用于预防和/或治疗血栓栓塞及其制备方法

摘要

In the present invention, there is disclosed an oral immediate release formulation in solid form containing: (a) a low molecular weight, peptide-based thrombin inhibitor having pH dependent solubility and having a particle size of less than 300 microns; and (b) a combination of microcrystalline cellulose and sodium starch glycolate in an amount higher than 35 percent by weight of the formulation. There is also disclosed a process for preparing such formulation, further medicinal use of a combination of the microcrystalline cellulose and sodium starch glycolate for the preparation of the formulation as well as the formulation for prophylaxis and/or treatment of thrombo-embolism.
机译:在本发明中,公开了一种固体形式的口服速释制剂,其包含:(a)低分子量的,基于肽的凝血酶抑制剂,其具有pH依赖性的溶解度,且粒径小于300微米; (b)微晶纤维素和羟乙酸淀粉钠的组合,其含量高于制剂重量的35%。还公开了制备这种制剂的方法,微晶纤维素和淀粉羟乙酸钠的组合的进一步医学用途,用于制备制剂以及预防和/或治疗血栓栓塞的制剂。

著录项

  • 公开/公告号CZ300830B6

    专利类型

  • 公开/公告日2009-08-19

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CZ20010000774

  • 申请日1999-08-27

  • 分类号A61K9/20;A61K;A61K9/14;A61K9/22;A61K31/397;A61K38;A61K38/04;A61K38/54;A61K38/55;A61K47/10;A61K47/36;A61K47/38;A61P;A61P7;A61P7/02;A61P43;

  • 国家 CZ

  • 入库时间 2022-08-21 19:28:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号